US Broker Ratings

QuidelOrtho Corporation (QDEL) Stock Analysis: Potential Upside of Over 50% Amidst Strategic Positioning in Healthcare

QuidelOrtho Corporation (NASDAQ: QDEL) is a compelling entity within the healthcare sector, focusing on medical devices. With a market capitalization of $1.54 billion, the company specializes..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Anticipating a 40% Upside with Strong Buy Ratings

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a promising player in the biotechnology sector, is garnering attention from investors with its significant 40.35% potential upside, as indicated by..

SS Innovations International (SSII) Stock Analysis: Unpacking the 192.5% Revenue Growth in the Healthcare Sector

In the dynamic landscape of the healthcare sector, India-based SS Innovations International Inc. (SSII) is making waves with its impressive revenue growth. The company, operating in..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 60% Upside Potential Amidst Healthcare Growth

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector, presents a compelling opportunity for investors seeking exposure to the medical care facilities industry...

ARS Pharmaceuticals, Inc. (SPRY): Analyst Consensus Sees 214% Upside Potential

Investors eyeing opportunities in the biotechnology sector may want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a promising player focusing on innovative..

Schrodinger, Inc. (SDGR) Stock Analysis: Investors Eye a Potential 93% Upside Amid Market Turbulence

Schrodinger, Inc. (NASDAQ: SDGR) is capturing investor attention with a compelling potential upside of 93.42%, according to recent analyst ratings. As a prominent player in the..

Artivion, Inc. (AORT) Stock Analysis: Exploring a 33% Upside Potential in the Medical Device Sector

Artivion, Inc. (AORT), a prominent player in the healthcare sector specializing in medical devices, has been attracting investor attention with its diverse product range and promising..

Concentra Group Holdings Parent (CON) Stock Analysis: 20% Upside Potential with Strong Buy Ratings

For investors eyeing opportunities in the healthcare sector, Concentra Group Holdings Parent, Inc. (CON) presents an intriguing proposition. With a market capitalization of $3.04 billion, the..

Indivior Pharmaceuticals, Inc. (INDV): Investor Outlook with 45% Potential Upside

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) has emerged as a compelling entity within the healthcare sector, particularly in the highly specialized space of drug manufacturing for opioid..

GeneDx Holdings Corp. (WGS): Analyst Ratings Signal a Promising 111% Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, has captured the attention of investors with..

Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 49.64% Potential Upside in the Healthcare Sector

For those attuned to investment opportunities in the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) presents a fascinating narrative. With its strategic focus on providing cutting-edge sample..

CONMED Corporation (CNMD) Investor Outlook: Exploring the Growth Potential and Analyst Consensus

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling case for investors looking to capitalize..

National HealthCare Corporation (NHC) Stock Analysis: A Look at Its Impressive 52-Week High and Growth Metrics

National HealthCare Corporation (NYSE: NHC) has recently caught the attention of investors as it reached its 52-week high at $171.15, marking a significant climb from the..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 58.84% Potential Upside in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) stands out in the healthcare sector, particularly within the medical devices industry. With a market cap of $1.58 billion, the company..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Strong Buy Ratings Amid Steady Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector specializing in medical instruments and supplies, has been capturing investor interest with its robust..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook on Its Promising 45% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its focus on developing therapies for rare neurological diseases. The company’s flagship..

Immunocore Holdings plc (IMCR) Stock Analysis: A Deep Dive into its 99% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR) has captured significant attention in the biotechnology sector, drawing investor interest with its promising pipeline and a robust potential upside of..

Arcellx, Inc. (ACLX) Stock Analysis: Navigating Biotech’s Cutting Edge with Strategic Alliances

Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, stands at the forefront of developing innovative immunotherapies aimed at tackling cancer and other challenging..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 77% Potential Upside with Strong Buy Ratings

Biohaven Ltd. (BHVN), a dynamic player in the biotechnology sector, is capturing investor attention with its promising pipeline of therapies and a remarkable potential upside of..

Omnicell, Inc. (OMCL) Stock Analysis: Strong Buy Ratings and Nearly 40% Upside Potential

Omnicell, Inc. (NASDAQ: OMCL) stands out as a compelling opportunity for investors seeking to tap into the healthcare technology sector. With a market capitalization of $1.89..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds